{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:39Z","timestamp":1776408699827,"version":"3.51.2"},"reference-count":27,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2026.2945","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:27:31Z","timestamp":1774610851000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Benefits and risks of prophylactic glucocorticoids in platinum chemotherapy for extensive\u2011stage small\u2011cell lung cancer: A retrospective study"],"prefix":"10.3892","volume":"24","author":[{"given":"Wang","family":"Qingling","sequence":"first","affiliation":[{"name":"Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Dafeng","sequence":"additional","affiliation":[{"name":"Department of General Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xuebo","sequence":"additional","affiliation":[{"name":"Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"key20260417085927_b1-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"key20260417085927_b2-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): Updated results from a randomised, controlled, open-label, phase 3 trial","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol"},{"key":"key20260417085927_b3-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2023.05.008","article-title":"Advancements in small cell lung cancer","volume":"93","author":"Lee","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"key20260417085927_b4-MCO-24-5-02945","author":"Zhu"},{"key":"key20260417085927_b5-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrclinonc.2017.71","article-title":"Unravelling the biology of SCLC: Implications for therapy","volume":"14","author":"Sabari","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260417085927_b6-MCO-24-5-02945"},{"key":"key20260417085927_b7-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/NOR.0000000000000595","article-title":"Corticosteroids","volume":"38","author":"Kapugi","year":"2019","journal-title":"Orthop Nurs"},{"key":"key20260417085927_b8-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1097\/CM9.0000000000002544","article-title":"Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"key20260417085927_b9-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: ASCO guideline update","volume":"38","author":"Hesketh","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20260417085927_b10-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common terminology criteria for adverse events (CTCAE-Version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"key20260417085927_b11-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: From the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"issue":"770","key":"key20260417085927_b12-MCO-24-5-02945","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050770","article-title":"Impact of glucocorticoid use in oncology in the immunotherapy era","volume":"11","author":"Kalfeist","year":"2022","journal-title":"Cells"},{"key":"key20260417085927_b13-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: Anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"key20260417085927_b14-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"key20260417085927_b15-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","volume":"44","author":"Pofi","year":"2023","journal-title":"Endocr Rev"},{"issue":"5797","key":"key20260417085927_b16-MCO-24-5-02945","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115797","article-title":"Mechanisms of nausea and vomiting: Current knowledge and recent advances in intracellular emetic signaling systems","volume":"22","author":"Zhong","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2921","key":"key20260417085927_b17-MCO-24-5-02945","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112921","article-title":"The role of glucocorticoids in inflammatory diseases","volume":"10","author":"Reichardt","year":"2021","journal-title":"Cells"},{"key":"key20260417085927_b18-MCO-24-5-02945","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"e115","key":"key20260417085927_b19-MCO-24-5-02945","article-title":"Development and validation of nomogram for predicting the risk of community-acquired pneumonia after kidney transplantation of deceased donors","volume":"1","author":"Li","year":"2025","journal-title":"Life Conflux"},{"key":"key20260417085927_b20-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.bbrc.2013.05.042","article-title":"Glucocorticoids attenuate septic acute kidney injury","volume":"435","author":"Choi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260417085927_b21-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10157-017-1448-z","article-title":"Guidelines for treatment of renal injury during cancer chemotherapy 2016","volume":"22","author":"Horie","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"key20260417085927_b22-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1200\/JCO.19.00189","article-title":"Immune checkpoint inhibitor outcomes for patients with non-small-cell lung cancer receiving baseline corticosteroids for palliative versus nonpalliative indications","volume":"37","author":"Ricciuti","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20260417085927_b23-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"key20260417085927_b24-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00467-011-1928-4","article-title":"Glucocorticoid-induced hypertension","volume":"27","author":"Goodwin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"key20260417085927_b25-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1136\/ard.2011.151464","article-title":"Glucose tolerance, insulin sensitivity and beta-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids","volume":"70","author":"Hoes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key20260417085927_b26-MCO-24-5-02945","doi-asserted-by":"publisher","first-page":"836","DOI":"10.4103\/ijem.IJEM_226_17","article-title":"Comparison of two protocols in the management of glucocorticoid-induced hyperglycemia among hospitalized patients","volume":"21","author":"Lakhani","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"issue":"8","key":"key20260417085927_b27-MCO-24-5-02945","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-023-00158-1","article-title":"Treatment of glucocorticoid- induced hyperglycemia in hospitalized patients-a systematic review and meta- analysis","volume":"10","author":"Struja","year":"2024","journal-title":"Clin Diabetes Endocrinol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:34Z","timestamp":1776405574000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2026.2945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2026.2945","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}